Reichenthal Max Alan

Director Reichenthal buys 2,000 FRD shares at $13.72; cluster pattern with 2 other insiders in 14 days

Reichenthal Max Alan, a director, purchased 2,000 shares of Friedman Industries at $13.72 on 2024-11-20, increasing his holdings by 6.5% to 32,761 shares total. This buy occurs as part of a cluster pattern, with 2 other insiders also purchasing within the past 14 days, suggesting coordinated conviction at current valuations. Examining his prior trading at FRD, the insider has demonstrated mixed timing: 2 of 4 prior buys were well-timed at the 90-day mark, with his 2024-06-26 purchase returning +2.7% over 90 days. However, the company faces headwinds—annual revenue has declined 5.7%, the firm posted a net loss of $-675.0K in the latest quarter, and the stock trades 22.5% below its 52-week high of $19.46. The cluster buy signals insider appetite despite these challenges, warranting monitoring to determine whether this represents early conviction in a turnaround or misjudgment amid deteriorating fundamentals.

Director Reichenthal buys 2,000 FRD shares at $14.00; stock now -26.7% from 52-week high.

Reichenthal, a director, purchased 2,000 shares at $14.00 on 2024-09-18, increasing his holdings by 2,000 shares to 30.8K shares post-transaction. The current price of $14.26 is -26.7% from the 52-week high of $19.46, and the stock has declined -11.0% over the past 90 days. His prior trades at FRD show mixed outcomes: a June 2024 buy generated +15.2% over 30 days (outcome not yet measurable at 90 days), while his August 2023 and September 2023 purchases at the same ticker produced negative 90-day returns of -10.3% and -5.8% respectively, with only 1 of 2 prior FRD buys well-timed at the 90-day mark. FRD's fundamentals show limited growth headwinds: revenue declined -5.7% year-over-year to $114.6M, net income is $2.6M, and the P/E of 8.15 suggests a valuation compressed from prior levels. The purchase occurs as the stock trades well below its recent highs, but the insider's track record at this specific ticker does not demonstrate consistent ability to identify inflection points.

Director Reichenthal buys 2,000 FRD shares at $14.89; stock now $14.76, down 24.2% from 52-week high.

Director Max Alan Reichenthal purchased 2,000 shares of Friedman Industries at $14.89 on 2024-08-16, increasing his holdings to 28.8K shares. The purchase occurs against deteriorating price momentum: the stock has declined 24.2% from its 52-week high and 11.3% over the past 30 days. At the same-ticker level, Reichenthal's prior three purchases show mixed outcomes—a June 2024 buy is up 15.2% at the 30-day mark, but his August 2023 purchase fell 10.3% over 90 days, and his September 2023 purchase gained only 0.6% over 90 days, with just one of three prior FRD trades well-timed at the 90-day horizon. The company's fundamentals are subdued: annual revenue has contracted 5.7% year-over-year, net income stands at $2.6M on $114.6M revenue, and the valuation at 8.43 P/E is modest. The purchase does represent a meaningful 7.5% increase in his position, but the mixed track record on timing at this ticker and the recent price weakness suggest this should be monitored rather than interpreted as a strong conviction signal.

Director Reichenthal bought 2,000 shares of FRD at $15.00 on 2024-06-26; cluster buy pattern with 2 other insiders in past 14 days.

Director Max Alan Reichenthal purchased 2,000 shares at $15.00 on 2024-06-26, increasing his holdings to 26,761 shares from 24,761 shares—a net addition of 8.1% to his prior position. This transaction is part of a cluster buy pattern, with 2 other insiders also purchasing shares within the past 14 days. However, the timing context is mixed: the stock is -22.4% from its 52-week high of $19.46 and down -16.4% over the past 30 days, though Reichenthal's prior trades at FRD showed one well-timed 90-day outcome (50% win rate on same ticker). Fundamentally, FRD carries a modest valuation at P/E 7.16 with recent revenue of $115,973,000.00 and annual revenue decline of -5.7%, which may explain the lower price but also signals structural headwinds for the business. The cluster buying by multiple insiders at a depressed price level warrants observation, though the mixed track record of Reichenthal's prior FRD purchases and the company's declining revenue growth temper the strength of the signal.